Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis

Osteoporosis is characterized by decreased bone mineral density and increased risk of fracture. Raloxifene is one of the treatments of osteoporosis. However, the responses were variable among patients. Previous studies revealed that the genetic variants are involved in the regulation of treatment ou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Dis Markers
Autors principals: Lu, Hsing-Fang, Chou, Po-Hsin, Lin, Gan-Hong, Chou, Wan-Hsuan, Wang, Shih-Tien, Adikusuma, Wirawan, Mugiyanto, Eko, Hung, Kuo-Sheng, Chang, Wei-Chiao
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479487/
https://ncbi.nlm.nih.gov/pubmed/32934756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8855423
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars